Breakthrough Psychedelic Drug Shows Promise in Treating Postpartum Depression - HealingMaps
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.| HealingMaps
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.| HealingMaps
More than 49,000 Americans died by suicide in 2022, representing a 3% jump over the previous year and the highest number in U.S. history.| HealingMaps
California Governor Gavin Newsom has said that his state is "all in" on expanding psychedelic therapy access.| HealingMaps
This white paper outlines the current, challenges, and potential solutions for incorporating psychedelics into mainstream medical practice.| HealingMaps
WSJ reporter Katherine Bindley breaks down the continued mainstreaming of psychedelic drug use in Silicon Valley.| HealingMaps
In this study, low-dose ketamine led to significant improvements in mood and cognition within just a few hours of treatment.| HealingMaps
